Epidemiologic cutoff values for antimicrobial agents against Aeromonas salmonicida isolates determined by frequency distributions of minimal inhibitory concentration and diameter of zone of inhibition data.

OBJECTIVE To develop epidemiologic cutoff values by use of frequency distributions for susceptibility to 4 antimicrobial agents when tested against a representative population of a major aquaculture pathogen, Aeromonas salmonicida. SAMPLE POPULATION 217 typical and atypical A salmonicida isolates obtained from 20 states and 12 countries. PROCEDURES Species identification of A salmonicida isolates was confirmed by detection of specific nucleotide sequences by use of a PCR assay. Minimal inhibitory concentration (MIC) and diameter of the zone of inhibition for oxytetracycline, ormetoprim-sulfadimethoxine, oxolinic acid, and florfenicol were determined for each isolate in accordance with standardized antimicrobial susceptibility testing methods that have been approved by the Clinical and Laboratory Standards Institute for bacterial isolates from aquatic animals. Susceptibility data were tabulated in a scattergram and analyzed by use of error rate bounding. RESULTS Susceptibility tests for oxytetracycline, ormetoprim-sulfadimethoxine, and oxolinic acid revealed 2 distinct populations of bacteria. Isolates tested against florfenicol clustered into a single population. Oxolinic acid susceptibility data revealed higher MICs in the non-United States A salmonicida isolates. Slow-growing (atypical) A salmonicida isolates were generally more susceptible than typical isolates for all antimicrobials, except oxolinic acid. CONCLUSIONS AND CLINICAL RELEVANCE Use of frequency distributions of susceptibility results to develop epidemiologic cutoff values appears to be applicable to aquatic isolates. Frequency distributions of susceptibility results for A salmonicida revealed clear divisions between isolate susceptibilities. This type of data, considered in conjunction with pharmacokinetic and efficacy data, may be useful for developing clinical breakpoints for use in aquaculture.

[1]  Renate Reimschuessel,et al.  Fish drug analysis—Phish-pharm: A searchable database of pharmacokinetics data in fish , 2005, The AAPS Journal.

[2]  Peter Smith,et al.  Towards setting breakpoints for oxolinic acid susceptibility of Aeromonas salmonicida using distribution of data generated by standard test protocols , 2005 .

[3]  R. Miller,et al.  Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria. , 2005, Diseases of aquatic organisms.

[4]  G. Kahlmeter,et al.  Harmonization of antimicrobial breakpoints in Europe — Can it be achieved? , 2004 .

[5]  R. Miller,et al.  Antimicrobial Susceptibility Testing of Aquatic Bacteria: Quality Control Disk Diffusion Ranges for Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 at 22 and 28°C , 2003, Journal of Clinical Microbiology.

[6]  R. Miller,et al.  Antimicrobial susceptibility testing of aquatic bacteria: quality control disk diffusion ranges for Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 at 22 and 28 degrees C. , 2003, Journal of clinical microbiology.

[7]  B. Kuehn.  Veterinarians test the waters of fish medicine. , 2002, Journal of the American Veterinary Medical Association.

[8]  T. Aoki,et al.  Rapid identification of Aeromonas salmonicida subspecies salmonicida by the polymerase chain reaction , 1996 .

[9]  C. Thomas,et al.  Detection of Aeromonas salmonicida from fish by using polymerase chain reaction amplification of the virulence surface array protein gene , 1992, Applied and environmental microbiology.

[10]  D. Alderman,et al.  Aeromonas salmonicida: development of resistance to 4-quinolone antimicrobials , 1989 .

[11]  C. Metzler,et al.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. , 1974, The Journal of infectious diseases.